Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia
L. Zhou, C. Ni, R. Liao, X. Tang, T. Yi, M. Ran, M. Huang, R. Liao, X. Zhou, D. Qin, L. Wang, F. Huang, X. Xie, Y. Wan, J. Luo, , J. Wu
This study shows vilazodone improves thrombocytopenia by activating SRC/MAPK signaling through 5-HT1A receptor in megakaryocyte differentiation.
bioRxiv · Dec 16, 2023Pharmacology & Toxicology